MARKET WIREReuters • 2h ago
Oil slips more than 1% as talks continue on ending Iran war - ReutersOil slips more than 1% as talks continue on ending Iran war Reuters
Why OFIX Stock advanced +1.99% Today — RQD Quant Desk Flash
$10.24 +1.99% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $10.26
Orthofix Medical Inc. (OFIX) carries a Roarable Rating of D+ (Sell) with 55/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE D+ • SELL / AVOID
Cap $417.1M
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER
Click Any Pre-Computed AI Quant Specialist Briefing on OFIX Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is OFIX stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-01, Orthofix Medical Inc. (NASDAQ: OFIX) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 55/100 at a spot price of $10.24 (+1.99% 1D, market cap $417.1M). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 15/20, and SEC Balance-Sheet Forensics 11/20. Across 1016 tracked Health Care issuers, OFIX ranks #280 in composite RQD confidence.
✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does OFIX compare to SI and CARL in the Health Care sector?
▼
Within the Health Care sector (Medical/Dental Instruments), OFIX carries a Roarable D+ (55/100 RQD), trailing P/E of N/A, gross margin of 68.8%, and ROIC of -12.2%. By comparison, SI (Shoulder Innovations Inc.) holds a D- grade (42/100 RQD, P/E N/A, ROIC -16.1%, cap $425.5M) and CARL (Carlsmed Inc.) posts a D- grade (39/100 RQD, P/E N/A, ROIC -35.0%, cap $430.6M). Among the 5-stock peer group, OFIX leads on earnings multiple (N/A) while OFIX leads on capital efficiency (-12.2% ROIC).
✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for OFIX?
▼
Per OFIX's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000884624), Orthofix Medical Inc. generated $822.3M in revenue (+2.9% YoY), -$92.2M in net income, and $33.3M in free cash flow against $850.6M in total assets and $157.4M in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.. Institutional options positioning shows a 50% call / 50% put premium split.
✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $10.26 (+0.17%)🧬 Cannibal Buyback (-0.96% YoY Shares)⚙️ Cash Engine: 8/20 (D-) • 4.1% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record: Scores of 55/100 (D+) historically posted market-perform odds over rolling 90-day windows (-0.5% avg 90D alpha vs SPY • 51.4% hit rate — wait for RQD ≥ 70 breakout).
Audit Bucket Track Record →RQD QUANT TACHOMETERSELL / AVOID • D+
2-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw D · Rk C
Each axis scored 0–20
12M PRICE TARGET CONE-1.4% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for OFIX)Realized 20D OHLCV Swing Band: ±8.9%
Deterministic 5-Pillar Attribution (55/100 Composite)
🔍 WHY OFIX SCORES 55/100 (D+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Macro Regime Fit+15/20 pts (27% of score)
FRED Regime × Technicals: 20% of 52W Range • RSI-14 at 42.3 (NEUTRAL RANGE)
▲ #2 Bullish Driver: Whale & Options Positioning+11/20 pts (20% of score)
20D Institutional Volume Accumulation (±8.9% realized swing band)
▼ #1 Drag / Risk Factor: Cash Engine Quality8/20 pts (-12 pt drag)
Capital intensity & 0% operating margin leave 12 pts on the table
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade D$9.17+2.3% Next Q
47
Q2 (-2Q)Grade C-$9.38+4.6% Next Q
50
Q3 (-1Q)Grade C-$9.81+4.4% Next Q
52
CurrentGrade D+$10.24-0.5% Hist 90D α
55
Trajectory: D (47) → D+ (55)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER
⚔️ Adversarial Opposing Case: Why the OFIX Bull Thesis Could Fail
Even with a 55/100 (D+) score, OFIX faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.
⚠️ Forensic Kill-Switch #1
Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.
⚠️ Forensic Kill-Switch #2
Dilution & Margin Drag: Cannibal Buyback (-0.96% YoY Shares) — any gross margin slip below 66.3% triggers an automatic RQD downgrade.
⚠️ Forensic Kill-Switch #3
Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($9.39) or 200D SMA ($11.10) invalidates the momentum regime and cuts Target Base ($10.10) toward Bear Floor ($7.88).
🎲 LIVE PREDICTION MARKET ODDS TIED TO $OFIX• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “OFIX Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why OFIX Stock advanced +1.99% Today — RQD Quant Desk Flash
Orthofix Medical Inc. (OFIX) advanced +1.99% to $10.24, trading at 20% of its 52-week range ($8.5 – $16.99). Stretched risk/reward at current multiples (-12% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 20% of its 52-week range ($8.5 – $16.99) with RSI-14 at 42.3 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±8.9% around $10.24 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D+ (Sell) backed by 68.8% gross margin and $33.3M annual free cash flow.
Live OFIX Headlines & Catalysts
MARKET WIREReuters • 3h ago
Nine people dead in Learjet crash in south Florida, officials say - ReutersNine people dead in Learjet crash in south Florida, officials say Reuters
MARKET WIREReuters • 5h ago
Iran's IRGC Navy says two tankers 'exploded' after hitting mines in Hormuz - ReutersIran's IRGC Navy says two tankers 'exploded' after hitting mines in Hormuz Reuters
MARKET WIRECNBC • 7h ago
Here are 3 big things we're watching in the stock market in the week aheadThe market could use a few victories in the days ahead, which will be filled with more earnings, an election, and jobs data.
MARKET WIRECNBC • 7h ago
Democratic Rep. Stevens endorses Rogers over El-Sayed in Michigan Senate electionHaley Stevens had lost the Democratic nomination for Senate in Michigan to Abdul El-Sayed earlier this year.
RISK WATCHReuters • 8h ago
Israeli strikes kill eight people in Gaza - medics say - ReutersIsraeli strikes kill eight people in Gaza - medics say Reuters
MARKET WIREReuters • 9h ago
Russia's FSB says minor detained over park attack threat after US tip-off - ReutersRussia's FSB says minor detained over park attack threat after US tip-off Reuters
MARKET WIREReuters • 10h ago
Iran, Qatari mediators hold third day of talks to end US-Iran war - ReutersIran, Qatari mediators hold third day of talks to end US-Iran war Reuters
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring OFIX)
- ✓Walkthrough of OFIX's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
OFIX // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -12.93%📐 HORIZONTAL RANGE
2026-10-30O $10.29H $10.29L $8.90C $10.24VOL 657.9K
RES: $12.51SUP: $8.33SMA50: $9.39SMA200: $11.10
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
OFIX Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth
vs. +2.9% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on OFIX today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for OFIX. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for OFIX today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (OFIX)
Health Care Rank #280 of 1016
⚔️ SI vs OFIX Full Matrix →
1. Head-to-Head Health Care Peer Comparison (OFIX vs. SI, CARL, NPCE, MOBI)
Industry: Medical/Dental Instruments (120 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, Orthofix Medical Inc. (OFIX) ranks #280 by composite RQD confidence (55/100, grade D+) and #475 by equity capitalization ($417.1M). Within this direct 5-issuer industry benchmark cohort, OFIX leads on earnings valuation at N/A trailing P/E, while OFIX leads on capital efficiency and profitability with -12.2% ROIC and 68.8% gross margin. OFIX currently leads its immediate peer cohort in composite quantitative strength at 55/100 (D+).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| OFIX
ACTIVE
Orthofix Medical Inc. | D+ | 55/100 | — | 68.8% | -12.2% | +1.99% | $417.1M | Benchmark Subject |
| SI Shoulder Innovations Inc. | D- | 42/100 | — | 76.5% | -16.1% | +4.93% | $425.5M | /si-vs-ofix → |
| CARL Carlsmed Inc. | D- | 39/100 | — | 75.3% | -35.0% | +3.01% | $430.6M | /carl-vs-ofix → |
| NPCE Neuropace Inc. | E | 30/100 | — | 77.2% | -23.0% | +0.62% | $446.6M | /npce-vs-ofix → |
| MOBI Mobia Medical Inc. | D | 46/100 | — | — | — | -4.41% | $375.2M | /mobi-vs-ofix → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000884624In its most recent audited fiscal period (FY2025, filed 2025-12-31), Orthofix Medical Inc. (OFIX) reported GAAP revenue of $822.3M (+2.9% vs. FY2024 revenue of $799.5M , and +10.1% cumulative change since FY2023) , GAAP net income of -$92.2M, operating cash flow of $33.3M, and free cash flow of $33.3M (+29.3% YoY). On the balance sheet, OFIX closed FY2025 with $850.6M in total assets against $157.4M in total debt (Altman Z-Score: 1.02, Piotroski F-Score: 7/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $822.3M | -$92.2M | $33.3M | $33.3M | $850.6M | $157.4M |
| FY2024 (FY) | 2024-12-31 | $799.5M | -$126.0M | $25.8M | $25.8M | $893.3M | $157.0M |
| FY2023 (FY) | 2023-12-31 | $746.6M | -$151.4M | -$45.8M | -$45.8M | — | — |
3. OFIX Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs OFIX stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, Orthofix Medical Inc. (NASDAQ: OFIX) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 55/100 at a spot price of $10.24 (+1.99% 1D, market cap $417.1M). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 15/20, and SEC Balance-Sheet Forensics 11/20. Across 1016 tracked Health Care issuers, OFIX ranks #280 in composite RQD confidence.
How does OFIX compare to SI and CARL in the Health Care sector?
Within the Health Care sector (Medical/Dental Instruments), OFIX carries a Roarable D+ (55/100 RQD), trailing P/E of N/A, gross margin of 68.8%, and ROIC of -12.2%. By comparison, SI (Shoulder Innovations Inc.) holds a D- grade (42/100 RQD, P/E N/A, ROIC -16.1%, cap $425.5M) and CARL (Carlsmed Inc.) posts a D- grade (39/100 RQD, P/E N/A, ROIC -35.0%, cap $430.6M). Among the 5-stock peer group, OFIX leads on earnings multiple (N/A) while OFIX leads on capital efficiency (-12.2% ROIC).
What are the biggest fundamental strengths and SEC risk factors for OFIX?
Per OFIX's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000884624), Orthofix Medical Inc. generated $822.3M in revenue (+2.9% YoY), -$92.2M in net income, and $33.3M in free cash flow against $850.6M in total assets and $157.4M in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is OFIX trading relative to its 50-day, 200-day, and 52-week technical levels?
OFIX last traded at $10.24 (+1.99% on volume of 399,270 shares), positioning the stock +9.05% above its 50-day simple moving average ($9.39) and -7.75% below its 200-day simple moving average ($11.10). Across its 52-week range of $8.50 to $16.99, OFIX sits at the 20.5% percentile with a 14-day RSI of 42.3 (NEUTRAL RANGE) and an implied next-earnings move of ±8.9% ($9.33 to $11.15).
OFIX Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is OFIX stock moving today?
Why OFIX Stock advanced +1.99% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-12% return on capital) under elevated 10-year interest-rate pressure.